Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 483.25 million compared to INR 360.78 million a year ago. Revenue was INR 484.94 million compared to INR 361.43 million a year ago. Net income was INR 60.19 million compared to INR 46.76 million a year ago. Basic earnings per share from continuing operations was INR 4.89 compared to INR 3.8 a year ago. Diluted earnings per share from continuing operations was INR 4.89 compared to INR 3.8 a year ago.